代谢综合征与肌萎缩侧索硬化风险:来自大规模前瞻性研究的见解
基于英国生物银行395987名参与者的前瞻性研究,中位随访13.7年记录539例肌萎缩侧索硬化(ALS)。校正混杂因素后,代谢综合征(MetS)与ALS风险升高相关(HR 1.50,95%CI 1.19-1.89),高血压和高甘油三酯分别与ALS风险升高相关。分层分析显示在BMI<25者中关联尤其显著。中介分析识别出碱性磷酸酶、胱抑素C、γ-谷氨酰转移酶及脂肪酸比例等潜在代谢中介物。
要点
- 代谢综合征与肌萎缩侧索硬化风险升高相关(HR 1.50,95%CI 1.19-1.89)。
- 高血压(HR 1.53,95%CI 1.19-1.95)和高甘油三酯(HR 1.31,95%CI 1.06-1.61)分别与ALS风险升高相关。
- 代谢异常数量与ALS风险显著相关,且在BMI<25者中关联尤其显著。
核心结论
- 代谢综合征与肌萎缩侧索硬化易感性升高呈稳健关联,在BMI较低者中尤其明显。
- 代谢物和代谢组学作为潜在中介,为复杂生物学机制提供了宝贵见解。
研究设计与样本
- 研究纳入英国生物银行395987名参与者,探讨代谢综合征与肌萎缩侧索硬化的关系。
- 采用Cox回归模型估计风险比(HR),并按性别、体重指数(BMI)、吸烟状况和教育水平进行分层分析。
- 进行中介分析以探索潜在机制。
主要发现
- 中位随访13.7年,共记录539例肌萎缩侧索硬化。
- 校正混杂因素后,代谢综合征(采用协调定义)患者发生ALS的风险更高(HR 1.50,95%CI 1.19-1.89)。
- 高血压与ALS风险升高相关(HR 1.53,95%CI 1.19-1.95),高甘油三酯与ALS风险升高相关(HR 1.31,95%CI 1.06-1.61)。
- 代谢异常数量与ALS风险呈显著结果。
- 分层分析显示,这些关联在BMI<25的个体中尤其显著。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Although metabolic abnormalities are implicated in the etiology of neurodegenerative diseases, their role in the development of amyotrophic lateral sclerosis (ALS) remains a subject of controversy. We aimed to identify the association between metabolic syndrome (MetS) and the risk of ALS. METHODS: This study included 395,987 participants from the UK Biobank to investigate the relationship between MetS and ALS. Cox regression model was used to estimate hazard ratios (HR). Stratified analyses were performed based on gender, body mass index (BMI), smoking status, and education level. Mediation analysis was conducted to explore potential mechanisms. RESULTS: In this study, a total of 539 cases of ALS were recorded after a median follow-up of 13.7 years. Patients with MetS (defined harmonized) had a higher risk of developing ALS after adjusting for confounding factors (HR: 1.50, 95% CI: 1.19-1.89). Specifically, hypertension and high triglycerides were linked to a higher risk of ALS (HR: 1.53, 95% CI: 1.19-1.95; HR: 1.31, 95% CI: 1.06-1.61, respectively). Moreover, the quantity of metabolic abnormalities showed significant results. Stratified analysis revealed that these associations are particularly significant in individuals with a BMI <25. These findings remained stable after sensitivity analysis. Notably, mediation analysis identified potential metabolites and metabolomic mediators, including alkaline phosphatase, cystatin C, γ-glutamyl transferase, saturated fatty acids to total fatty acids percentage, and omega-6 fatty acids to omega-3 fatty acids ratio. INTERPRETATION: MetS exhibits a robust association with an increased susceptibility to ALS, particularly in individuals with a lower BMI. Furthermore, metabolites and metabolomics, as potential mediators, provide invaluable insights into the intricate biological mechanisms. ANN NEUROL 2024;96:788-801.
引用
- Zhang J, Cao W, Xie J, et al. Metabolic Syndrome and Risk of Amyotrophic Lateral Sclerosis: Insights from a Large-Scale Prospective Study. Ann Neurol. 2024. PMID: 38934512. doi:10.1002/ana.27019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。